PubAg

Main content area

Nigella sativa oil modulates the therapeutic efficacy of mesenchymal stem cells against liver injury in irradiated rats

Author:
Radwan, Rasha R., Mohamed, Heba A.
Source:
Journal of photochemistry and photobiology 2018 v.178 pp. 447-456
ISSN:
1011-1344
Subject:
Nigella sativa, alanine transaminase, aspartate transaminase, blood serum, cell transplantation, gamma radiation, histopathology, interleukin-10, interleukin-6, intravenous injection, irradiation, liver, liver diseases, malondialdehyde, medicine, oils, patients, radiotherapy, rats, stem cells, superoxide dismutase, tissue repair, tissues, transforming growth factor beta, tumor necrosis factor-alpha
Abstract:
Stem cell transplantation is a novel strategy for regenerative medicine in liver disease. This study was conducted to explore the modulatory effect of Nigella sativa oil (NSO) on the therapeutic potential of mesenchymal stem cells (MSCs) against irradiation-induced liver damage in rats. Liver damage was induced by a total body exposure to a single dose of 7Gy. NSO (2mg/kg/day) was then given orally for 4 consecutive weeks starting 24h after irradiation with or without a single intravenous MSCs administration, then rats were sacrificed four weeks after exposure to γ radiation. Data revealed that irradiation elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities in serum, increased hepatic malondialdehyde (MDA) content and reduced hepatic superoxide dismutase (SOD) activity. Furthermore, it caused elevation in pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) associated with reduction in anti-inflammatory cytokine interleukin-10 (IL-10) and it increased fibrogenic marker transforming growth factor-β (TGF-β) in liver tissues. It was observed that combined NSO/MSCs therapy provided more beneficial tissue repair comparable to MSCs alone as demonstrated by modulating the tested parameters. Finally, these results were confirmed by histopathological examination. In conclusion, dual therapy with NSO and MSCs could serve as a promising approach for alleviating radiation-induced liver injury in patients with radiotherapy.
Agid:
5937579